Links

LLM approach expert levels in ophthalmology. Price controls in health care (Argentina) Will bird flu (H5N1) animal pandemic spread to humans? Lex Fridman interview with Mark Cuban (with discussion of Cost Plus Drugs) Spotlight on Medicare’s Chronic Care Management program.

Links

Generative AI for economists. Juvenile curfews on teenage birth rates. Cato on Biden Short‐​Term Health Plans Rule. Parents’ education on children’s earnings. DTx for MDD.

Links

FDA on AI. Rural hospital closures on maternal and infant health. Price caps for obesity drugs? One framework for fair drug pricing. Iterative approach to model-based decision making in health.

Links

The future of economics. Hacker attack on health data.  Where is air pollution highest in low- and middle-income countries. 5.8m children have long COVID Underrated: the HPV vaccine.

Thursday Links

How NICE has applied it’s disease severity modifier. Non-profit hospitals and bond ratings. Calculating cell & gene therapy breakeven point using RWD. Public vs. private Medicaid. Supplementing VA with private insurance.

Links

VR surgery for PPE. SNAP, food insecurity and medication adherence. Hospital racial composition and VBP. Drinking and jobs (part 1, part 2) Geographies with ultra-low fertility.

Links

More people want to expand ACA vs. repeal it. What is a person’s social cost of being corrected by AI? Guidance on the promise and pitfalls of using AI in healthcare. “….people systematically misremember their past policy preferences regarding how to best fight the Covid-19 pandemic” Consequentialists vs. deontologists: “…which moral principle prevails appears to…

Friday Links

Impact of the Great Recession on health. A loneliness epidemic? Medicaid’s increasing pressure on state budgets. Physician reimbursement to decline 3.4%. Are children spending too much time on enrichment activities?

Mid-week Links

ABIM on physician certification. 70.4% of physicians worked while on vacation on a typical vacation day Is Science a public good? Healthcare job growth reached three-decade high. Is there a future for digital therapeutics?